Back to Results

Greenrose Acquisition Corp (GNRSQ)

Greenrose Acquisition Corp (GNRSQ) is a common stock listing on OTC Markets tied to Greenrose Holding Company Inc. The company filed a voluntary Chapter 7 liquidation petition on June 18, 2024, in the U.S. Bankruptcy Court for the Eastern District of New York. Before the filing, through its subsidiaries, it was involved in cannabis operations, including the cultivation, processing, packaging, production, and sale of medical cannabis and related derivative products. Founded in 2014 and based in Amityville, New York, the company operated in the healthcare and pharmaceuticals area.


Stock Summary Fair Value Profitability & Growth Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Dividend Yield Next Earnings Date Market Cap
OTC-GNRS.Q
Not available
Not available
Not available
0.0%
December 2, 2026
0.017 K
Valuation • Fair Value

Greenrose Acquisition Corp (OTC-GNRS.Q) Fair Value by Valuation Model

No usable valuation estimate is currently available for Greenrose Acquisition Corp (OTC-GNRS.Q); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Greenrose Acquisition Corp (OTC-GNRS.Q). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Greenrose Acquisition Corp (OTC-GNRS.Q)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Greenrose Acquisition Corp (OTC-GNRS.Q) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Events • Dividends

Upcoming Events & Dividends for Greenrose Acquisition Corp (OTC-GNRS.Q)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

December 2, 2026

Days to Earnings

71

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Greenrose Acquisition Corp (OTC-GNRS.Q), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Greenrose Acquisition Corp (OTC-GNRS.Q) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Buy

The 1-hour technical read for Greenrose Acquisition Corp (OTC-GNRS.Q) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Greenrose Acquisition Corp (OTC-GNRS.Q) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Greenrose Acquisition Corp (OTC-GNRS.Q) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for Greenrose Acquisition Corp (OTC-GNRS.Q) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Greenrose Acquisition Corp (OTC-GNRS.Q) Stock FAQ

Data-supported answers about Greenrose Acquisition Corp (OTC-GNRS.Q), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs

A reliable fair value estimate is not currently available for Greenrose Acquisition Corp (OTC-GNRS.Q). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The next earnings date currently listed for Greenrose Acquisition Corp (OTC-GNRS.Q) is December 2, 2026.

The latest available data indicates no current dividend yield for Greenrose Acquisition Corp (OTC-GNRS.Q).

The current market capitalization listed for Greenrose Acquisition Corp is 0.017 K.

The ticker symbol for Greenrose Acquisition Corp is OTC-GNRS.Q, and the stock is listed on OTC Markets.

Greenrose Acquisition Corp (OTC-GNRS.Q) is listed on OTC Markets.

Similar Pharmaceuticals Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

LLY NYSE Eli Lilly and Company Fair Value Fair Market Cap 1,043 B
JNJ NYSE Johnson & Johnson Fair Value Fair Market Cap 648.7 B
MRK NYSE Merck & Company Inc Fair Value Fair Market Cap 372.3 B
NVS NYSE Novartis AG ADR Fair Value Fair Market Cap 269.8 B
NVO NYSE Novo Nordisk A/S Fair Value Bargain Market Cap 175.3 B
PFE NYSE Pfizer Inc Fair Value Fair Market Cap 159.2 B
BMY NYSE Bristol-Myers Squibb Company Fair Value Fair Market Cap 127.2 B
SNY NASDAQ Sanofi ADR Fair Value Undervalued Market Cap 102 B
GSK NYSE GSK plc DRC Fair Value Undervalued Market Cap 101.9 B
TAK NYSE Takeda Pharmaceutical Co Ltd ADR Fair Value Fair Market Cap 60.536 B
TEVA NYSE Teva Pharma Industries Ltd ADR Fair Value Fair Market Cap 46.053 B
HLN NYSE HALEON PLC ADR Fair Value Fair Market Cap 40.268 B
RPRX NASDAQ Royalty Pharma Plc Fair Value Fair Market Cap 33.639 B
ZTS NYSE Zoetis Inc Fair Value Bargain Market Cap 30.107 B
VTRS NASDAQ Viatris Inc Fair Value Undervalued Market Cap 19.733 B
JAZZ NASDAQ Jazz Pharmaceuticals PLC Fair Value Fair Market Cap 15.616 B
CORT NASDAQ Corcept Therapeutics Incorporated Fair Value Overvalued Market Cap 12.702 B
ELAN NYSE Elanco Animal Health Fair Value Fair Market Cap 11.456 B
AXSM NASDAQ Axsome Therapeutics Inc Fair Value Fair Market Cap 10.639 B
RDY NYSE Dr. Reddy’s Laboratories Ltd ADR Fair Value Fair Market Cap 10.564 B